506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL)
Phase II-Study With Nelarabine in Patients With Refractory Oder Relapsed T- ALL or T-lymphoblastic Lymphoma (Amend.7)